Clinical Focus

The new workflow enables scalable, high-throughput analysis of hundreds to thousands of single cells, advancing applications in cancer research, drug development, and precision medicine

Direct in sample sequencing, or DISS, is a high-demand and transformative technology that unlocks library-prep free research possibilities across a variety of new use cases

VeraBIND™ Tau is a new noninvasive test that offers 96 percent sensitivity and 90 percent specificity, empowering earlier and more accessible Alzheimer's detection

New xGen™ hybridization and wash offering is poised to revolutionize targeted next generation sequencing workflows

As the frequency of late-stage cancer diagnoses rises, more accurate and efficient screening methods are needed to address overspending and improve early detection outcomes

This new publication sets the standard, enabling more personalized and targeted breast cancer prevention and detection

Resources offering guidance on HIV drug resistance, testing strategies, and surveillance

Collaboration to leverage Oxford Nanopore's sequencing platform and Cepheid's GeneXpert system to advance the field of sequencing for infectious diseases

New treatments are moving away from open surgery and toward minimally invasive techniques

The need for clinical lab managers to communicate effectively ran the gamut from testing information to hiring and compliance

PROSTOX ultra is the first and only molecular diagnostic test to use biology and genetics to predict radiation toxicity

The results could spur more rigorous preventive measures that stop hidden spread of the disease

The Today's Clinical Lab 2025 Cancer & Precision Medicine print issue features cancer screening successes, emerging technologies, and advances in targeted treatments

Recent new and emerging technologies in the field of laboratory medicine from the 2025 April Cancer & Precision Medicine issue of Today's Clinical Lab

Small changes in fragmentation lead to significant shifts in data quality. See the comparison

A new study finds that many eligible patients who receive other preventive screenings are not getting screened for lung cancer

Among the pregnant women, the researchers found that certain groups had higher Long COVID risks than others

Why labs need to be prepared year-round to detect respiratory pathogens and help protect the broader community

The FDA LDT rule would have imposed unnecessary burdens on laboratories, adding requirements beyond existing CLIA regulations

About 1,900 scientists warn that actions being taken by the current administration will slow scientific advances and harm Americans